Cellular regulation of blood coagulation: A model for venous stasis

Blood

Volumn 116, Issue 26, 2010, Pages 6082-6091

  Campbell, James E ^a   Brummel Ziedins, Kathleen E ^a   Butenas, Saulius ^a   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5A; FIBRINOPEPTIDE A; LIPOPOLYSACCHARIDE; PROTEIN C; RECOMBINANT THROMBOPLASTIN; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM; VENOUS STASIS;

EID: 78650651123     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-266395     Document Type: Article

References (85)

1. Virchow R. Thrombose und Embolie. Gefassent-zundung und septische Infektion. Gesammelte Abhandlungen zur wissenschlaflichen Medicin, Frankfurk am Main: Von Meidinger & Sohn. 1856:219-732 [Trans: Matzdorff AC, Bell WR. Canton, Massachusetts: Science History Publications; 1998].
2. Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F. Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol. 2000;35(5):255-259. (Pubitemid 34215118)
3. Chavez JJ, Foley DE, Snider CC, et al. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass. Anesth Analg. 2004;99(5):1290-1294; table of contents.
4. Beguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost. 1989;61(1):25-29.
5. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA. 2006;296(4):397-402.
6. Lawson JH, Kalafatis M, Stram S, Mann KG. A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem. 1994;269(37):23357- 23366.
7. van't Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Syner-gistic effect in combination with tissue factor pathway inhibitor. J Biol Chem. 1997;272(12):7983-7994.
8. Butenas S, van't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem. 1997;272(34):21527-21533.
9. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem. 2002;277(21):18322-18333.
10. Jones KC, Mann KG. Amodel for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem. 1994;269(37):23367-23373.
11. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood. 1996;88(9):3432-3445.
12. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood. 2002;100(1):148-152.
13. Cawthern KM, van't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood. 1998;91(12):4581- 4592.
14. Orfeo T, Brummel-Ziedins KE, Gissel M, Butenas S, Mann KG. The nature of the stable blood clot proco-agulant activities. J Biol Chem. 2008;283(15):9776-9786.
15. Brummel-Ziedins KE, Pouliot RL, Mann KG. Thrombin generation: phenotypic quantitation. J Thromb Haemost. 2004;2(2):281-288.
16. Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L. Platelet deposition induced by severely damaged vessel wall is inhibited by a boro-arginine synthetic peptide with antithrombin activity. Thromb Haemost. 1994;71(4):511-516.
17. Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Blood. 1991;78(2):423-434.
18. Badimon L, Badimon JJ, Turitto VT, Vallabhajo-sula S, Fuster V. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation. 1988;78(6):1431-1442.
19. Hockin MF, Kalafatis M, Shatos M, Mann KG. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells. Arterio-scler Thromb Vasc Biol. 1997;17(11):2765-2775.
20. Turner N, Nolasco L, Tao Z, Dong JF, Moake J. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost. 2006;4(6):1396-1404.
21. Shatos MA, Orfeo T, Doherty JM, Penar PL, Collen D, Mann KG. Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15(7):903-911.
22. Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothe-lium, and expanded polytetrafluoroethylene. J Lab Clin Med. 1987;110(6):706-718.
23. Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d'Apice AJ, Cowan PJ. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant. 2008;8(6):1101-1112.
24. Grau GE, Mili N, Lou JN, et al. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest. 1996;74(4):761-770.
25. Zhu DZ, Cheng CF, Pauli BU. Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc Natl Acad Sci U S A. 1991;88(21):9568-9572.
26. Milici AJ, Furie MB, Carley WW. The formation of fenestrations and channels by capillary endothe-lium in vitro. Proc Natl Acad Sci U S A. 1985;82(18):6181-6185.
27. Hampel B, Fortschegger K, Ressler S, et al. Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp Gerontol. 2006;41(5):474-481.
28. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987;79(1):124-130.
29. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80(12):3734-3737.
30. Edgell CJ, Haizlip JE, Bagnell CR, et al. Endothe-lium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol. 1990;26(12):1167-1172.
31. Schaefer HI, van't Hooft FM, van der Laarse A. Growth characteristics of a permanent human endothelial cell line. In Vitro Cell Dev Biol. 1992;28 A (7-8): 465-467.
32. Bouis D, Hospers GA, Meijer C, Molema G, Mulder NH. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis. 2001;4(2):91-102.
33. Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 2002;100(8):2787-2792.
34. Mezzano D, Matus V, Saez CG, Pereira J, Panes O. Tissue factor storage, synthesis and function in normal and activated human platelets. Thromb Res. 2008;122(suppl 1): S31-S36.
35. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood. 2005;105(7):2764-2770.
36. Bouchard BA, Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood. 2010;116(5):854-855.
37. Parhami-Seren B, Butenas S, Krudysz-Amblo J, Mann KG. Immunologic quantitation of tissue factors. J Thromb Haemost. 2006;4(8):1747-1755.
38. Edwards RL, Rickles FR, Bobrove AM. Mono-nuclear cell tissue factor: cell of origin and requirements for activation. Blood. 1979;54(2):359-370.
39. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol. 1994;88(2):364-371.
40. Egorina EM, Sovershaev MA, Bjorkoy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol. 2005;25(7):1493-1498.
41. Tracy PB, Robinson RA, Worfolk LA, Allen DH. Procoagulant activities expressed by peripheral blood mononuclear cells. Methods Enzymol. 1993;222:281-299.
42. Sovershaev MA, Egorina EM, Gruber FX, Olsen JO, Osterud B. High tissue factor-expressing human monocytes carry low surface CD36: application to intersubject variability. J Thromb Haemost. 2007;5(12):2453-2460.
43. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG. The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost. 2005;3(7):1472-1481.
44. Foster WB, Tucker MM, Katzmann JA, Miller RS, Nesheim ME, Mann KG. Monoclonal antibodies to human coagulation factor V and factor Va. Blood. 1983;61(6):1060-1067.
45. Butenas S, Parhami-Seren B, Mann KG. The influence of von Willebrand factor on factor VIII activity measurements. J Thromb Haemost. 2009;7(1):132-137.
46. Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phos-pholipid vesicles. J Biol Chem. 1983;258(10):6503-6508.
47. Brooks EG, Trotman W, Wadsworth MP, et al. Valves of the deep venous system: an overlooked risk factor. Blood. 2009;114(6):1276-1279.
48. Taatjes DJ, Wadsworth MP, Zaman AK, Schneider DJ, Sobel BE. A novel dual staining method for identification of apoptotic cells reveals a modest apoptotic response in infarcted mouse myocardium. Histochem Cell Biol. 2007;128(3):275-283.
49. Butenas S, Parhami-Seren B, Gissel MT, Amblo J, Brummel-Ziedins K, Mann KG. The nature of LPS-stimulated monocyte tissue factor activity. Blood. 2008;112(11):375-376. Abstract 1022.
50. Henriksson CE, Hellum M, Landsverk KS, Klin-genberg O, Joo GB, Kierulf P. Flow cytometry-sorted non-viable endotoxin-treated human monocytes are strongly procoagulant. Thromb Haemost. 2006;96(1):29-37.
51. Mann KG. Thrombin formation. Chest. 2003;124(3 suppl): 4S-10S.
52. Mann KG, Orfeo T, Butenas S, Undas A, Brummel-Ziedins K. Blood coagulation dynamics in haemostasis. Hamostaseologie. 2009;29(1):7-16.
53. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem. 1999;274(32):22862-22870.
54. van't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichio-metric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem. 1997;272(7):4367-4377.
55. Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioim-munoassay of factor V in human plasma and platelets. Blood. 1982;60(1):59-63.
56. Maruyama I, Majerus PW. The turnover of throm-bin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem. 1985;260(29):15432-15438.
57. Sato N, Kokame K, Miyata T, Kato H. Lysophos-phatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells. Thromb Haemost. 1998;79(1):217-221.
58. Wilbourn B, Harrison P, Lawrie A, et al. Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cells. Br J Haematol. 1992;81(3):401-406.
59. Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol. 2009;29(12):1989-1996.
60. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;32(1):11-23.
61. Butenas S, Orfeo T, Mann KG. Tissue factor activity and function in blood coagulation. Thromb Res. 2008;122(suppl 1): S42-S46.
62. Breider MA, Yang Z. Tissue factor expression in bovine endothelial cells induced by Pasteurella haemolytica lipopolysaccharide and interleukin-1. Vet Pathol. 1994;31(1):55-60.
63. Yang HL, Lu FJ, Wung SL, Chiu HC. Humic acid induces expression of tissue factor by cultured endothelial cells: regulation by cytosolic calcium and protein kinase C. Thromb Haemost. 1994;71(3):325-330.
64. Faucette KJ, Fitzgerald LA, Liu L, Parker CJ, Rodgers GM. Characterization of the interactions between procoagulant albumin and human endo-thelial cells. Blood. 1993;82(9):2684-2692.
65. van der Logt CP, Dirven RJ, Reitsma PH, Bertina RM. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul Fibrinolysis. 1994;5(2):211-220.
66. Osterud B. Tissue factor expression in blood cells. Thromb Res. 2010;125(suppl 1): S31-S34.
67. Rodgers GM, Broze GJ Jr, Shuman MA. The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood. 1984;63(2):434-438.
68. Reuning U, Preissner KT, Muller-Berghaus G. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa. Thromb Haemost. 1993;69(2):197-204.
69. Camera M, Giesen PL, Fallon J, et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19(3):531-537.
70. Hockin MF, Cawthern KM, Kalafatis M, Mann KG. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition. Biochemistry. 1999;38(21):6918-6934.
71. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269(50):31869-31880.
72. Esmon CT. The protein C pathway. Chest. 2003;124(3 suppl): 26S-32S.
73. Mann KG, Hockin MF, Begin KJ, Kalafatis M. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem. 1997;272(33):20678-20683.
74. Kalafatis M, Mann KG. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem. 1993;268(36):27246-27257.
75. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745-2756.
76. Castellot JJ Jr, Addonizio ML, Rosenberg R, Kar-novsky MJ. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol. 1981;90(2):372-379.
77. Goldsmith JC, McCormick JJ, Yen A. Endothelial cell cycle kinetics. Changes in culture and correlation with endothelial properties. Lab Invest. 1984;51(6):643-647.
78. Adragna NC. Changes in cation composition of aortic endothelial cells in culture. Tissue Cell. 1988;20(3):313-329.
79. Fry GL. Modification of phenotypic-expression of human vascular endothelium in culture. Arteriosclerosis. 1988;8(5):A666-A666.
80. Rodriguez-Morata A, Garzon I, Alaminos M, et al. Cell viability and prostacyclin release in cultured human umbilical vein endothelial cells. Ann Vasc Surg. 2008;22(3):440-448.
81. Brown ML, Deykin D. Passage state affects ara-chidonic acid content and eicosanoid release in porcine aortic endothelial cells. Arterioscler Thromb. 1991;11(1):167-173.
82. Hoffman M, Cooper ST. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms. Blood Cells Mol Dis. 1995;21(2):156-167.
83. Kessels H, Willems G, Hemker HC. Analysis of thrombin generation in plasma. Comput Biol Med. 1994;24(4):277-288.
84. Downing MR, Bloom JW, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry. 1978;17(13):2649-2653.
85. Xu J, Esmon NL, Esmon CT. Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem. 1999;274(10):6704-6710.